Identification and characterization of renal cell carcinoma gene markers

Cancer Informatics

Volumn 3, Issue , 2007, Pages 65-92

  Dalgin, Gul S ^a   Holloway, Dustin T ^a   Liou, Louis S ^b   DeLisi, Charles ^a,c  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Boston University   (United States)

Author keywords

Biomarker identification; Cancer diagnosis; Microarray analysis; Renal cell carcinoma

Indexed keywords

ABELSON KINASE; BIOLOGICAL MARKER; CD81 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYTOCHROME P450 2B6; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FIBROBLAST GROWTH FACTOR 9; GLUTARYL COENZYME A DEHYDROGENASE; HLA A24 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; RIBOSOME PROTEIN; SODIUM CHLORIDE COTRANSPORTER; TUMOR MARKER; UVOMORULIN; VASCULOTROPIN; VITAMIN D RECEPTOR; WISKOTT ALDRICH SYNDROME PROTEIN;

ANTIGEN PRESENTATION; ARTICLE; CALCIUM SIGNALING; CANCER DIAGNOSIS; CATION TRANSPORT; CELL ADHESION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FATTY ACID METABOLISM; GENE EXPRESSION PROFILING; GENE FUNCTION; GLYCOLYSIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTRACELLULAR TRANSPORT; KIDNEY CARCINOMA; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; ONCOGENE; OXIDATIVE PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SUPPORT VECTOR MACHINE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; WISKOTT ALDRICH SYNDROME; ABL2 GENE; AXL GENE; CDKN1C GENE; CLASSIFIER; GENE EXPRESSION; HIERARCHICAL CLUSTERING; JAZF1 GENE; MARKER GENE; PAPPA GENE; PRINCIPAL COMPONENT ANALYSIS; PTPRO GENE; RASD1 GENE; RENAL CELL CARCINOMA; TFAP2A GENE; WASF2 GENE;

EID: 34547215963     PISSN: 11769351     EISSN: 11769351     Source Type: Journal    
DOI: 10.1177/117693510700300006     Document Type: Article

References (52)

1. Albrechtsson, E., Jonsson, T. and Moller, S. et al. 2003. Vitamin d receptor is expressed in pancreatic cancer cells and a vitamin d3 analogue decreases cell number. Pancreatology, 3:41-6.
2. Alon, U., Barkai, N. and Notterman, D.A. et al. 1999. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A., 96:6745-50.
3. Boer, J.M., Huber, W.K. and Sultmann, H. et al. 2001. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cdna array. Genome Res., 11:1861-170.
4. Bussey, K.J., Kane, D. and Sunshine, M. et al. 2003. Matchminer: A tool for batch navigation among gene and gene product identifiers. Genome Biol., 4:R27.
5. Chevrollier, A., Loiseau, D. and Gautier, F. et al. 2005. Ant2 expression under hypoxic conditions produces opposite cell-cycle behavior in 143b and hepg2 cancer cells. Mol. Carcinog., 42:1-8.
6. Dalgin, G.S. and DeLisi, C. 2005. Simple discriminant functions identify small sets of genes that distinguish cancer phenotype from normal. Genome Inform Ser. Workshop Genome Inform., 16:245-53.
7. de, Castro, J., Belda-Iniesta, C. and Cejas, P. et al. 2003. New insights in beta-tubulin sequence analysis in non-small cell lung cancer. Lung Cancer, 41:41-8.
8. Dennis, G., Sherman, B.T. and Hosack, D.A. et al. 2003. David: Database for annotation, visualization, and integrated discovery. Genome Biol., 4:P3.
9. Gieseg, M.A., Cody, T. and Man, M.Z. et al. 2002. Expression profiling of human renal carcinomas with functional taxonomic analysis. BMC Bioinformatics, 3:26.
10. Golub, T.R., Slonim, D.K. and Tamayo, P. et al. 1999. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science, 286:531-7.
11. Guyon, I., Weston, J. and Barnhill, S. et al. 2002. Gene selection for cancer classification using support vector machines. Machine Learning, 46:389-422.
12. Hanahan, D. and Weinberg, R.A. 2000. The hallmarks of cancer. Cell, 100:57-70.
13. Heddi, A., Faure-Vigny, H. and Wallace, D.C. et al. 1996. Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma. Biochim. Biophys. Acta., 1316:203-9.
14. Higgins, J.P., Shinghal, R. and Gill, H. et al. 2003. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am. J. Pathol., 162:925-32.
15. Holloway, D., Kon, M. and DeLisi, C. 2005. Integrating genomic data to predict transcription factor binding. Genome Inform Ser. Workshop Genome Inform., 16:83-94.
16. Holloway, D., Kon, M. and DeLisi, C. 2006a. Machine learning for predicting targets of transcription factors in yeast. Synthetic and Systems Biology, in press.
17. Holloway, D., Kon, M. and DeLisi, C. 2006b. Machine learning for predicting transcription data integration. IBM Journal of Research and Development on Systems Biology, in press.
18. Huang, H.Y., Ladanyi, M. and Soslow, R.A. 2004. Molecular detection of jazf1-jjaz1 gene fusion in endometrial stromal neoplasms with classic and variant histology: Evidence for genetic heterogeneity. Am. J. Surg. Pathol., 28:224-32.
19. Inoue, G., Horiike, N. and Onji, M. 2001. The cd81 expression in liver in hepatocellular carcinoma. Int. J. Mol. Med., 7:67-71.
20. Ishiguro, H., Shimokawa, T. and Tsunoda, T. et al. 2002. Isolation of helad1, a novel human helicase gene up-regulated in colorectal carcinomas. Oncogene., 21:6387-94.
21. Jean, D., Gershenwald, J.E. and Huang, S. et al. 1998. Loss of ap-2 results in up-regulation of mcam/muc18 and an increase in tumor growth and metastasis of human melanoma cells. J. Biol. Chem., 173:16501-8.
22. Jemal, A., Murray, T. and Samuels, A. et al. 2003. Cancer statistics. CA Cancer J. Clin., 53:5-26.
23. Jones, J., Otu, H. and Spentzos, D. et al. 2005. Gene signatures of progression and metastasis in renal cell cancer. Clin. Cancer Res., 11:5730-9.
24. Karjalainen, J.M., Kellokoski, J.K. and Eskelinen, M.J. et al. 1998. Downregulation of transcription factor ap-2 predicts poor survival in stage i cutaneous malignant melanoma. J. Clin. Oncol., 16:3584-91.
25. Khanim, F.L., Gommersall, L.M. and Wood, V.H. et al. 2004. Altered smrt levels disrupt vitamin d3 receptor signalling in prostate cancer cells. Oncogene., 23:6712-25.
26. Kimura, N., Pilichowska, M. and Okamoto, H. et al. 2000. Immunohistochemical expression of chromogranins a and b, prohormone convertases 2 and 3, and amidating enzyme in carcinoid tumors and pancreatic endocrine tumors. Mod. Pathol., 13:140-6.
27. Lenburg, M.E., Liou, L.S. and Gerry, N.P. et al. 2003. Previously unidentified changes in renal cell carcinomas gene expression identified by parametric analysis of microarray data. BMC Cancer, 3:31.
28. Lotfi, M., Sastry, A. and Ye, M. et al.1994. Hla-dq and tap2 genes in patients with insulin-dependent diabetes mellitus. Immunol. Lett., 41:201-4.
29. Lu, H., Forbes, R.A. and Verma, A. 2002. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the warburg effect in carcinogenesis. J. Biol. Chem., 277:23111-5.
30. Ma, X.J., Salunga, R. and Tuggle, J.T. et al. 2003. Gene expression profiles of human breast cancer progression. Proc. Natl. Acad. Sci. U.S.A., 100:5974-9.
31. Meierhofer, D., Mayr, J.A. and Foetschl, U. et al. 2004. Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis, 25:1005-10.
32. Mercier, I., Vuolo, M. and Madan, R. et al. 2005. Arc, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo- and radiation-resistance. Cell. Death. Differ., 12:682-6.
33. Mozzetti, S., Ferlini, C. and Concolino, P. et al. 2005. Class iii beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin. Cancer. Res., 11:298-305.
34. Ojika, T., Imaizumi, M. and Abe, T. et al. 1991. Immunochemical and immunohistochemical studies on three aldolase isozymes in human lung cancer. Cancer Res., 67:2153-8.
35. Penfornis, A., Tuomilehto-Wolf, E. and Faustman, D.L. et al. 2002. Analysis of tap2 polymorphisms in finnish individuals with type i diabetes. Hum. Immunol., 63:61-70.
36. Reddy, T.E., DeLisi, C. and Shakhnovich, B.E. 2005. Assessing transcription factor motif drift from noisy decoy sequences. Genome Inform., 16:59-67.
37. Sasatomi, T., Suefuji, Y. and Matsunaga, K. et al. 2002. Expression of tumor rejection antigens in colorectal carcinomas. Cancer, 94:1636-41.
38. Shi, T., Liou, L.S. and Sadhukhan, P. et al. 2004. Effects of resveratrol on gene expression in renal cell carcinoma. Cancer Biol. Ther., 3:882-8.
39. Sholkopf, B. and Smola, A.J. 2002. Learning with kernels. The MIT Press. Cambridge, M.A.
40. Simonnet, H., Alazard, N. and Pfeiffer, K. et al. 2002. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis, 23:759-68.
41. Sultmann, H., von Heydebreck, A. and Huber W. et al. 2005. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival. Clin. Cancer Res., 11:646-55.
42. Takahashi, M., Rhodes, D.R. and Furge, K.A. et al. 2001. Gene expression profiling of clear cell carcinoma: Gene identification and prognostic classification. Proc. Natl. Acad. Sci. U.S.A., 98:9754-9.
43. Takahashi, M., Yang, X.J. and Sugimura, J. et al. 2003. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene., 22:6810-8.
44. Takashi, M., Sakata, T. and Kato, K. 1993. Use of serum gamma-enolase and aldolase a in combination as markers for renal cell carcinoma. Jpn. J. Cancer Res., 84:304-9.
45. Vapnik, V. 1998. Statistical learning theory. John Wiley & Sons, New York.
46. Warburg, O. 1956. On the origin of cancer cells. Science, 123:309-14.
47. Wu, C.W., Li, A.F. and Chi, C.W. et al. 2003. Arg tyrosine kinase expression in human gastric adenocarcinoma is associated with vessel invasion. Anticancer Res., 23:205-10.
48. Xu, X.L., Wu, L.C. and Du, F. et al. 2001. Inactivation of human srbc, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res., 61:7943-9.
49. Yagasaki, F., Wakao, D. and Yokoyama, Y. et al. 2001. Fusion of etv6 to fibroblast growth factor receptor 3 in peripheral t-cell lymphoma with at (4; 12)(p16; p13) chromosomal translocation. Cancer Res., 61:8371-4.
50. Yamazaki, K., Sakamoto, M. and Ohta, T. et al. 2003. Overexpression of kit in chromophobe renal cell carcinoma. Oncogene., 22:847-52.
51. Young, A.N., Amin, M.B. and Moreno, C.S. et al. 2001. Expression profiling of renal epithelial neoplasms: A method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol., 158:1639-51.
52. Young, A.N., de Oliveira, Salles, P.G. and Lim, S.D. et al. 2003. Beta defensin-1, parvalbumin, and vimentin: A panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cdna microarrays. Am. J. Surg. Pathol., 27:199-205.